Clinical trial
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in…
NCT00248456 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00248456 |
|---|---|
| Title | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris |
| Official title | A Randomised, Double-blind, Active-controlled, Parallel, Multi-center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris |
| Lead sponsor | LEO Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psoriasis Vulgaris |
| Intervention type | Drug |
| Interventions | Calcipotriol plus betamethasone dipropionate ointment |
| Enrollment | 320 |
| Start date | Oct 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Nov 4, 2005 |
| Last update posted | Feb 24, 2025 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: